Zephyr® Endobronchical Valves:
Optimizing Outcomes in Bronchoscopic
Lung Volume Reduction Procedures
Designed for current bronchoscopic lung volume practitioners, a panel of BLVR experts will discuss their individual approaches to a variety of clinical challenges, including treating homogenous patients, pneumothorax mitigation and treatment, and their evolving patient selection criteria in the post-LIBERATE era.
Register
"*" indicates required fields
Alma Gaucha Restaurant
Tuesday, October 8, 2024, 6:30 – 8:30 p.m.
401 D Street, Boston, MA 02210
Dinner will be provided*
Jonathan Kurman,
MD, MBA
Director, Interventional Pulmonology
Froedtert & Medical College of Wisconsin
Milwaukee, WI
Amit “Bobby” Mahajan,
MD, FCCP, DAABIP
Medical Director, Interventional Pulmonology & Complex Airway
Disease Program
Inova Fairfax Hospital
Fairfax, VA
Kevin Ma, MDP
Medical Director, Interventional Clinical Director, Bronchoscopic Lung Volume Reduction Program
Associate Professor of Clinical Medicine (Pulmonary, Allergy and Critical Care), University of Pennsylvania
Philadelphia, PA
*Pulmonx Corporation is required to report transfers of value (e.g. meals) related to this educational
event in compliance with the Sunshine Act.
Speakers are paid consultants of Pulmonx Corporation.
© 2023-Present Pulmonx Corp or its affiliates. All rights reserved. All trademarks herein are the property of Pulmonx Corporation and its affiliates.
US-EN-1986-v1